Author | Yukimichi Kawada, MD, PhD

Articles

Endocrine Plus Uracil/Tegafur Therapy for Prostate Cancer

July 01, 1999

ByYoshinari Ono, MD, PhD|Ohinichi Ohshima, MD, PhD|Yoshito Takahashi, MD, PhD|Manabu Kuriyama, MD, PhD|Yukimichi Kawada, MD, PhD

A prospective, randomized clinical trial was conducted to evaluate the efficacy of endocrine chemotherapy with uracil and tegafur (in a molar ratio of 4:1 [UFT]) in patients with prostate cancer. The study included two